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ABSTRACT
Background. Living donor kidney transplantation (LDKT) pro-
vides more timely access to transplantation and better clinical
outcomes than deceased donor kidney transplantation
(DDKT). This study investigated disparities in the utilization of
LDKT in the UK.
Methods.A total of 2055 adults undergoing kidney transplanta-
tion between November 2011 and March 2013 were prospec-
tively recruited from all 23 UK transplant centres as part of the
Access to Transplantation and Transplant Outcome Measures
(ATTOM) study. Recipient variables independently associated
with receipt of LDKT versus DDKTwere identified.
Results. Of the 2055 patients, 807 (39.3%) received LDKT and
1248 (60.7%) received DDKT. Multivariable modelling demon-
strated a significant reduction in the likelihood of LDKT for
older age {odds ratio [OR] 0.11 [95% confidence interval (CI)
0.08–0.17], P< 0.0001 for 65–75 years versus 18–34 years};
Asian ethnicity [OR 0.55 (95% CI 0.39–0.77), P¼ 0.0006 versus
White]; Black ethnicity [OR 0.64 (95% CI 0.42–0.99), P¼ 0.047
versus White]; divorced, separated or widowed [OR 0.63 (95%
CI 0.46–0.88), P¼ 0.030 versus married]; no qualifications [OR
0.55 (95% CI 0.42–0.74), P< 0.0001 versus higher education
qualifications]; no car ownership [OR 0.51 (95% CI 0.37–0.72),
P¼ 0.0001] and no home ownership [OR 0.65 (95% CI 0.85–
0.79), P¼ 0.002]. The odds of LDKT varied significantly
between countries in the UK.
Conclusions. Among patients undergoing kidney transplanta-
tion in the UK, there are significant age, ethnic, socio-economic
and geographic disparities in the utilization of LDKT. Further
work is needed to explore the potential for targeted interven-
tions to improve equity in living donor transplantation.
Keywords: inequity, kidney transplantation, living donor, pre-
emptive transplantation, sociodemographic disparities
INTRODUCTION
For patients with end-stage renal disease (ESRD), living
donor kidney transplantation (LDKT) provides better clinical
outcomes and more timely access to transplantation than
deceased donor kidney transplantation (DDKT) [1–3].
Current UK Renal Association guidelines recommend that
LDKT be considered the treatment of choice for all patients
suitable for kidney transplantation, whenever an appropriate
living donor is available [4]. In contrast to the lengthy waiting
time for DDKT, the LDKT procedure can be scheduled with-
out delay, thereby minimizing the time that patients are
exposed to pre-transplant dialysis and its associated morbid-
ity, or enabling avoidance of dialysis entirely (pre-emptive
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transplantation). Pre-emptive LDKT is considered by many
to be an optimal treatment, providing superior graft and
patient survival compared with kidney transplantation fol-
lowing a period of dialysis [2, 4–6].
Despite these advantages, only one-third of kidney trans-
plants undertaken in the UK are from living donors [7].
Internationally, the UK falls behind many other countries in
terms of LDKT activity [8]. A recent strategy set out by
National Health Service Blood and Transplant (NHSBT)
aims to increase LDKT activity in the UK from the current
rate of 17 transplants per million population (pmp) to 26
transplants pmp by 2020 [9].
There are limited data on the factors that may prevent or
enable patients to receive LDKT in the UK. A better under-
standing of these factors will facilitate the identification of
target patient groups and aid the development of appropriate
interventions to improve LDKT rates. The principal aim of
this study was to identify the recipient characteristics associ-
ated with achieving LDKT compared with DDKT in a
national sample of UK kidney transplant recipients. The
study was conducted as part of the Access to Transplantation
and Transplant Outcome Measures (ATTOM) research
programme.
MATERIALS AND METHODS
Study population
ATTOM is a national prospective cohort study investigat-
ing the factors that influence access, clinical and patient-
reported outcomes and cost-effectiveness of renal transplan-
tation in the UK. A full description of the ATTOM study
methods and protocol has been reported previously [10]. As
part of the ATTOM study, incident kidney transplant recipi-
ents were recruited at the time of transplantation from all 23
UK renal transplant centres. In each centre, recruitment took
place over a 12-month period, between 1 November 2011 and
31 March 2013. Patients 18–75 years of age were eligible for
inclusion. A total of 3002 patients received kidney-only trans-
plants in the UK within the recruitment period; 134 were out-
side the study age criteria and 775 declined to participate or
were not able to be approached for recruitment. In all, 38 of
2093 recruited patients were excluded from the analysis due
to missing data for the main outcome variable (living or
deceased donor). Thus the final analysis cohort of 2055
patients represented 72% of eligible study participants
(Figure 1). There were no significant differences in the age,
gender or ethnicity distributions between study participants
and the national registry adult kidney transplant recipient
population (data not shown) [11].
Data collection
Extensive demographic, socio-economic, clinical and comor-
bidity data were collected for each patient at the time of trans-
plantation. Trained research nurses collected uniformly defined
data items from patient interviews, case notes and local elec-
tronic patient information systems.
Ethnicity was coded as White, Black, Asian or other (includ-
ing patients of Chinese and mixed origin). The level of highest
educational attainment was coded as no qualifications, qualifi-
cations at the secondary education level or equivalent [e.g.
General Certificate of Secondary Education (GCSE), General
Certificate of Education Advanced level (A-level), “National
Vocational Qualification (NVQ) level 1-3]” or qualifications at
FIGURE 1: Study population (asterisk refers to recruitment that took place over a 12-month period in each centre between 1 November 2011
and 31 March 2013).
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|the higher education level or equivalent (e.g. bachelor’s degree,
higher degree, “NVQ level 4–5)”. Employment status was coded
as employed (including full time, part time or self-employed),
unemployed, long-term sick/disabled, retired or other (includ-
ing those looking after the family home, those not in work for
some other reason and students). The primary renal diagnosis
was classified by ERA-EDTA codes [12]. Donor details and
recipient calculated reaction frequency (cRF) were obtained
from linkage to UK Transplant Registry data. The cRF is a
measure of recipient human leucocyte antigen (HLA) sensitiza-
tion, calculated as the percentage of 10 000 recent donors to
which the recipient has pre-formed HLA antibodies. A comor-
bidity score was calculated for each patient using a modified
Charlson comorbidity index for patients with ESRD [13]. The
index consists of weighted scores assigned to 14 comorbid con-
ditions (myocardial infarction, congestive heart failure, periph-
eral vascular disease, cerebrovascular disease, dementia, chronic
pulmonary disease, rheumatological disease, peptic ulcer dis-
ease, diabetes without complications, diabetes with complica-
tions, leukaemia, lymphoma, moderate–severe liver disease and
metastatic disease). Our data set did not include two of the con-
ditions (rheumatological disease and peptic ulcer disease).
Scores were therefore calculated from the remaining 12
variables.
Statistical methods
Baseline characteristics of LDKT and DDKT recipients and
donors were compared by chi-squared tests for categorical data
andWilcoxon tests for non-parametric continuous data.
Recipient variables associated with receiving LDKT versus
DDKTwere analysed using logistic regression. Variables leading
to a change in log likelihood at P< 0.15 on univariable analysis
were entered into the multivariable model. The importance of
each variable in the multivariable model was tested by examin-
ing the difference in log likelihood between the model with and
without the variable. If the difference was not significant
(P> 0.05) the variable was removed. Each time a variable was
removed, the effect of removing each of the remaining variables
was retested until the most parsimonious model was achieved.
Potential interactions between variables were tested, none were
significant. Less than 7% of values were missing for any variable.
For modelling purposes, missing values were imputed using the
fully conditional specification logistic regression method. In all,
10 imputed data sets were modelled separately then combined
to produce final parameter estimates. Sensitivity analysis using
casewise deletion of missing values did not change conclusions.
Complex links between socio-economic deprivation and eth-
nicity with respect to access to and outcomes from renal
replacement therapy (RRT) have previously been reported [14,
15]. To avoid any confounding and/or interaction from ethnic-
ity, a subgroup analysis was undertaken in White patients only,
using the same multivariable modelling methods as described
above.
A second subgroup analysis examined the recipient variables
associated with receiving a transplant pre-emptively versus
post-initiation of dialysis in the LDKT cohort. Multivariable
modelling methods were the same as described above.
All data were analysed using SAS 9.4 (SAS Institute, Cary,
NC, USA).
RESULTS
Type of transplant received
Of 2055 kidney transplant recipients, 1248 (60.7%) received
DDKT (583 donors after brain death and 665 donors after cir-
culatory death) and 807 (39.3%) received LDKT. A significantly
higher proportion of LDKT recipients received pre-emptive
transplants compared with DDKT recipients (35.5% versus
12.0%; P< 0.0001).
Recipient characteristics
There were considerable differences in the characteristics of
LDKT versus DDKT recipients (Table 1). LDKT recipients
were significantly younger than DDKT recipients (median age
46 versus 53 years) and a higher proportion were of White eth-
nicity (87.1 versus 79.5%) and married or living with a partner
(65.1 versus 60.5%). LDKT recipients were more likely to have
obtained qualifications at the secondary education level (53.0
versus 47.9%) and at the higher education level (27.3 versus
18.3%). Compared with DDKT recipients, LDKT recipients had
higher rates of employment (43.7 versus 31.3%), car ownership
(91.0 versus 80.2%) and home ownership (66.1 versus 62.0%),
suggesting they were a less socio-economically deprived popula-
tion. The cause of renal failure was less likely to be diabetes,
hypertension or renal vascular disease in the LDKT group.
LDKT recipients had a significantly lower prevalence of comor-
bidity compared with DDKT recipients. The proportion of kid-
ney transplants that were LDKTs was significantly higher in
Northern Ireland (NI) at 68.5%, compared with 39.0% in
England, 36.6% inWales and 31.2% in Scotland.
Donor characteristics
Characteristics of the donors are shown in Tables 2 and 3.
Living donors were significantly younger and more likely to be
female than deceased donors. A higher proportion of deceased
donors were of White ethnicity compared with living donors. A
total of 354 (43.9%) living donors were not genetically related to
the recipient. Parent, child, other blood relative and spouse liv-
ing donors were more likely to be female. Pooled/altruistic liv-
ing donors had the highest proportion ofWhite donors.
Factors associated with the probability of LDKT among
transplant recipients
Associations between recipient variables and the likelihood
of LDKT versus DDKT were characterized using univariable
and multivariable logistic regression (Table 4, Figure 2). The
multivariable model demonstrated that with each sequential
increase in age group, there was a marked reduction in the
probability of LDKT versus DDKT, such that patients 65–75
years of age were ~90% less likely to undergo LDKT compared
with patients 18–34 years of age {odds ratio [OR] 0.11 [95%
confidence interval (CI) 0.08–0.17], P< 0.0001}. Compared
with White patients, Asian patients [OR 0.55 (95% CI 0.39–
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Table 1. Kidney transplant recipient characteristics by type of donor
Living donor transplant recipients (n¼ 807) Deceased donor transplant recipients (n¼ 1248) P-value*
Demographic variables
Median age, years 46 (34–56) 53 (44–63) <0.0001
Age group (years) <0.0001
18–34 229 (28.4) 128 (10.3)
35–49 261 (32.3) 359 (28.8)
50–64 249 (30.9) 526 (42.2)
65–75 68 (8.4) 235 (18.8)
Gender 0.191
Male 493 (61.1) 798 (63.9)
Female 314 (38.9) 450 (36.1)
Ethnicitya 0.0002
White 703 (87.1) 989 (79.5)
Asian 61 (7.6) 138 (11.1)
Black 35 (4.3) 94 (7.6)
Other 8 (1.0) 23 (1.9)
Socio-economic variables
Civil statusa <0.0001
Married/living with partner 494 (65.1) 697 (60.5)
Divorced/separated/widowed 66 (8.7) 201 (17.5)
Single 199 (26.2) 254 (22.1)
Qualificationsa <0.0001
Higher education 207 (27.3) 210 (18.3)
Secondary education 402 (53.0) 551 (47.9)
No qualifications 150 (19.8) 390 (33.9)
Employment statusa <0.0001
Employed 332 (43.7) 361 (31.3)
Unemployed 59 (7.8) 92 (8.0)
Long-term sick/disability 182 (24.0) 343 (29.7)
Retired 112 (14.7) 287 (24.9)
Other 75 (9.9) 71 (6.2)
Car ownershipa 691 (91.0) 928 (80.2) <0.0001
Home ownershipa 501 (66.1) 716 (62.0) 0.068
Clinical variables
Primary renal diagnosisa <0.0001
Diabetic nephropathy 48 (6.0) 132 (10.6)
Glomerulonephritis 229 (28.5) 311 (24.9)
Polycystic kidney disease 113 (14.1) 209 (16.8)
Pyelonephritis 127 (15.8) 133 (10.7)
Hypertensive nephropathy 37 (4.6) 86 (6.9)
Renal vascular disease 10 (1.2) 27 (2.2)
Other 156 (19.4) 193 (15.5)
Uncertain 84 (10.5) 156 (12.5)
Charlson comorbidity scorea <0.0001
0 625 (77.7) 851 (68.4)
1 91 (11.3) 168 (13.5)
2 59 (7.3) 136 (10.9)
3 29 (3.6) 90 (7.2)
Previous transplant 117 (14.5) 157 (12.6) 0.212
Highly sensitized (cRF > 85%)a 96 (11.9) 119 (9.5) 0.086
Pre-transplant treatment modalitya <0.0001
Haemodialysis 351 (43.7) 718 (57.6)
Haemodiafiltration 14 (1.7) 39 (3.1)
Continuous ambulatory peritoneal dialysis 73 (9.1) 204 (16.4)
Automated peritoneal dialysis 67 (8.3) 130 (10.4)
Failing transplant 14 (1.7) 6 (0.5)
Pre-emptive 285 (35.5) 150 (12.0)
Geographic variables
Country <0.0001
England 670 (83.0) 1049 (84.1)
Wales 34 (4.2) 59 (4.7)
Northern Ireland 50 (6.2) 23 (1.8)
Scotland 53 (6.6) 117 (9.4)
Data are median (IQR) or number (%).
aData are missing for some participants and excluded from percentage calculations. Numbers of missing data are shown in Supplementary data, Table S1.
*Wilcoxon test for age. All others chi-squared test.
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|0.77), P¼ 0.0006] and Black patients [OR 0.64 (95% CI 0.42–
0.99), P¼ 0.047] were less likely to undergo LDKT than DDKT.
Patients who were divorced, separated or widowed had a lower
probability of LDKT compared with patients who were married
or living with a partner [OR 0.63 (95% CI 0.46–0.88), P¼ 0.03].
Having no formal qualifications [OR 0.55 (95% CI 0.42–0.74),
P< 0.0001] and having only secondary education qualifications
[OR 0.76 (95% CI 0.59–0.97), P¼ 0.01] reduced the odds of
LDKT compared with patients with higher education qualifica-
tions. Not owning a car [OR 0.51 (95% CI 0.37–0.72),
P< 0.0001] and not owning a home [OR 0.65 (95% CI 0.49–
0.85), P¼ 0.002] decreased the odds of LDKT versus DDKT.
With adjustment for recipient variables, the odds of LDKT ver-
sus DDKT were >3-fold higher for patients in NI [OR 3.25
(95% CI 1.89–5.57), P< 0.0001] compared with patients in
England. Further analysis showed the odds of LDKT in NI were
also higher compared with Wales [OR 3.77 (95% CI 1.88–7.56),
P¼ 0.0002] and Scotland [OR 4.53 (95% CI 2.42–8.48),
P< 0.0001], but there were no significant differences between
patients in England,Wales and Scotland.
Factors associated with the probability of LDKT among
White ethnicity transplant recipients
The same analysis was undertaken in a subgroup of White
patients only (n ¼ 1692) and confirmed that the effects of
socio-economic factors on the likelihood of LDKT versus
DDKTwere independent of ethnicity (Table 5).
Factors associated with the probability of pre-emptive
transplantation among living donor kidney transplant
recipients
A further subgroup analysis in the LDKT group examined
factors associated with achieving pre-emptive transplantation
versus transplantation after the initiation of dialysis (Table 6).
Patients with missing data for pre-transplant treatment modal-
ity (n ¼ 3) and patients with a previous transplant (n ¼ 117)
were excluded, leaving a final cohort of 687 LDKT recipients.
Multivariable analysis demonstrated a significantly decreased
likelihood of pre-emptive LDKT for Asian patients [OR 0.45
(95% CI 0.23–0.86), P¼ 0.016], unemployed patients [OR 0.44
(95% CI 0.21–0.92), P¼ 0.029], patients unable to work due to
long-term sickness/disability [OR 0.44 (95% CI 0.28–0.68),
P¼ 0.0002], retired patients [OR 0.47 (95% CI 0.29–0.75),
P¼ 0.002], not owning a car [OR 0.41 (95% CI 0.19–0.86),
P¼ 0.018] and not owning a home [OR 0.65 (95% CI 0.44–
0.96), P¼ 0.029].
DISCUSSION
Among patients undergoing kidney transplantation in the UK,
there are significant age, ethnic, socio-economic and geographic
Table 3. Living donor characteristics by donor–recipient relationship
Living donors (n¼ 807)
Parent
[n¼ 147 (18.2%)]
Child
[n¼ 75 (9.3%)]
Sibling
[n¼ 196 (24.3%)]
Other blood relative
[n¼ 35 (4.3%)]
Spouse/partner
[n¼ 188 (23.3%)]
Pooled/altruistic
[n¼ 93 (11.5%)]
Other non-related
[n¼ 73 (9.1%)]
Age groupa (years)
18–34 0 (0.0) 51 (68.0) 49 (25.0) 5 (14.7) 10 (5.3) 12 (12.9) 14 (19.2)
35–49 33 (22.5) 24 (32.0) 94 (48.0) 14 (41.2) 69 (36.7) 29 (31.2) 32 (43.8)
50–64 94 (64.0) 0 (0.0) 44 (22.5) 15 (44.1) 94 (50.0) 38 (40.9) 22 (30.1)
65–75 20 (13.6) 0 (0.0) 9 (4.6) 0 (0.0) 15 (8.0) 12 (12.9) 5 (6.9)
>75 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (2.2) 0 (0.0)
Gendera
Male 62 (42.2) 34 (45.3) 99 (50.5) 16 (47.1) 72 (38.3) 50 (53.8) 43 (59.7)
Female 85 (57.8) 41 (54.7) 97 (49.5) 18 (53.0) 116 (61.7) 43 (46.2) 29 (40.3)
Ethnicitya
White 132 (89.8) 64 (85.3) 169 (86.2) 30 (88.2) 170 (90.4) 86 (92.5) 65 (89.0)
Asian 9 (6.1) 5 (6.7) 15 (7.7) 2 (5.9) 11 (5.9) 2 (2.2) 6 (8.2)
Black 2 (1.4) 5 (6.7) 10 (5.1) 2 (5.9) 4 (2.1) 4 (4.3) 1 (1.4)
Other 4 (2.7) 1 (1.3) 2 (1.0) 0 (0.0) 3 (1.6) 1 (1.1) 1 (1.4)
Data are number (%).
aData are missing for some participants and excluded from percentage calculations. Numbers of missing data are shown in Supplementary data, Table S1.
Table 2. Donor characteristics
Living donor
(n¼ 807)
Deceased donor
(n¼ 1248)
P-value*
Median age, years 48 (39–57) 54 (42–64) <0.0001
Age groupa (years) <0.0001
<18 0 (0.0) 28 (2.2)
18–34 141 (17.5) 156 (12.5)
35–49 295 (36.6) 296 (23.7)
50–64 307 (38.1) 497 (39.8)
65–75 61 (7.6) 236 (18.9)
>75 2 (0.3) 35 (2.8)
Gendera 0.002
Male 376 (46.7) 671 (53.8)
Female 429 (53.3) 577 (46.2)
Ethnicitya <0.0001
White 716 (88.8) 1169 (95.0)
Asian 50 (6.2) 22 (1.8)
Black 28 (3.5) 22 (1.8)
Other 12 (1.5) 17 (1.4)
Data are median (IQR) or number (%).
aData are missing for some participants and excluded from percentage calculations.
Numbers of missing data are shown in Supplementary data, Table S1.
*Wilcoxon test for age. All others chi-squared test.
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Table 4. Univariable and multivariable logistic regression analysis of factors associated with LDKT versus DDKT
Univariable Multivariable
OR (95% CI) P-value OR (95% CI) P-value
Demographic variables
Age group (years)
18–34 1 (reference) 1 (reference)
35–49 0.41 (0.31–0.53) <0.0001 0.34 (0.25–0.46) <0.0001
50–64 0.27 (0.20–0.34) <0.0001 0.19 (0.14–0.27) <0.0001
65–75 0.16 (0.11–0.23) <0.0001 0.11 (0.08–0.17) <0.0001
Gender
Male 1 (reference)
Female 1.13 (0.94–1.36) 0.192
Ethnicity
White 1 (reference) 1 (reference)
Asian 0.62 (0.45–0.85) 0.003 0.55 (0.39–0.77) 0.0006
Black 0.52 (0.35–0.78) 0.001 0.64 (0.42–0.99) 0.047
Other 0.49 (0.22–1.10) 0.081 0.46 (0.19–1.11) 0.084
Socio-economic variables
Civil status
Married/living with partner 1 (reference) 1 (reference)
Divorced/separated/widowed 0.46 (0.34–0.63) <0.0001 0.63 (0.46–0.88) 0.030
Single 1.10 (0.88–1.36) 0.406 0.77 (0.58–1.02) 0.067
Qualifications
Higher education 1 (reference) 1 (reference)
Secondary education 0.73 (0.58–0.92) 0.009 0.76 (0.59–0.97) 0.010
No qualifications 0.39 (0.30–0.51) <0.0001 0.55 (0.42–0.74) <0.0001
Employment status
Employed 1 (reference)
Unemployed 0.71 (0.50–1.02) 0.064
Long-term sick/disability 0.58 (0.46–0.73) <0.0001
Retired 0.42 (0.33–0.55) <0.0001
Other 1.12 (0.79–1.58) 0.542
Car ownership
Yes 1 (reference) 1 (reference)
No 0.41 (0.31–0.55) <0.0001 0.51 (0.37–0.72) 0.0001
Home ownership
Yes 1 (reference) 1 (reference)
No 0.82 (0.68–1.00) 0.053 0.65 (0.49–0.85) 0.002
Clinical variables
Primary renal diagnosis
Diabetic nephropathy 1 (reference)
Glomerulonephritis 2.03 (1.40–2.94) 0.0002
Polycystic kidney disease 1.48 (0.99–2.22) 0.054
Pyelonephritis 2.62 (1.74–3.95) <0.0001
Hypertensive nephropathy 1.19 (0.72–1.98) 0.498
Renal vascular disease 1.02 (0.46–2.26) 0.968
Other 2.22 (1.50–3.29) <0.0001
Uncertain 1.48 (0.97–2.27) 0.068
Charlson comorbidity score
0 1 (reference)
1 0.74 (0.56–0.97) 0.031
2 0.59 (0.43–0.82) 0.002
3 0.45 (0.30–0.70) 0.0003
Previous transplant
No 1 (reference)
Yes 1.18 (0.91–1.53) 0.212
Highly sensitized (cRF > 85%)
No 1 (reference)
Yes 1.28 (0.97–1.71) 0.087
Geographic variables
England 1 (reference) 1 (reference)
Wales 0.90 (0.59–1.39) 0.642 0.86 (0.54–1.38) 0.539
Northern Ireland 3.40 (2.06–5.63) <0.0001 3.25 (1.89–5.57) <0.0001
Scotland 0.71 (0.51–1.00) 0.047 0.72 (0.50–1.03) 0.073
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disparities in the utilization of LDKT versus DDKT. Older age;
Black and Asian ethnicity; being divorced, separated or wid-
owed; lower educational attainment and measures of greater
socio-economic deprivation (non-car and non-home owner-
ship) were significantly and independently associated with a
reduced likelihood of LDKT versus DDKT. For the period of
the study, geographic differences were also noted, with patients
in NI having a greater probability of LDKT versus DDKT com-
pared with patients in the rest of the UK. Furthermore, the
study demonstrated that among those who do undergo LDKT,
ethnic and socio-economic disparities persist in determining
whether LDKT is received pre-emptively. Asian ethnicity,
unemployment and greater socio-economic deprivation were
associated with a lower likelihood of pre-emptive LDKT versus
LDKT after the initiation of dialysis.
A major strength of the present study is that we recruited all
patients prospectively and collected accurate, reliable and com-
prehensive data. A large proportion (72%) of the national adult
kidney transplant population was included in the study.
Nevertheless, as it was not possible to recruit the entire kidney
transplant population, it must be recognized that the study is
limited by a risk of selection bias. Reassuringly, the age, gender
and ethnicity of study participants were not significantly differ-
ent from the national adult kidney transplant population [11].
Furthermore, the study cohort included patients from all 23 UK
renal transplant centres as well as nationally comparable pro-
portions of LDKT, DDKT and pre-emptive recipients, thereby
reducing the potential for bias. However, differences in other
unmeasured characteristics between study participants and
non-participants cannot be ruled out. Another limitation of the
study is that we were unable to account for the fact that some
patients may not have had a medically suitable living donor.
This could be a potential explanation for the observed lower uti-
lization of LDKT for certain patient groups. It is known that
ethnic minorities have a higher prevalence of hypertension and
diabetes with associated ESRD, thus precluding kidney dona-
tion [16, 17]. Similarly, greater socio-economic deprivation is
linked to poorer health [18], potentially limiting the pool of liv-
ing donors available to more deprived patients. Furthermore,
due to the observational nature of the study, the results can only
describe associations and thus the causality of the observed rela-
tionships cannot be inferred.
In recent years, a great deal of attention has been directed
towards disparities in access to DDKT in the UK. Individuals
who are older, more socially deprived, from ethnic minority
backgrounds or treated in certain transplant centres are less
likely to be listed for and subsequently receive DDKT [19–23].
Despite LDKT providing optimal clinical outcomes for patients
with ESRD, there have been limited data on whether patients
experience disparities in utilizing this treatment. Udayaraj et al.
[24], reported a lower probability of LDKT for patients with
greater socio-economic deprivation and patients from Black
and South Asian backgrounds in the UK. However, this study
analysed the rates of LDKT among patients starting RRT, there-
fore a major confounding factor is the poorer health among
more socio-economically deprived and ethnic minority popula-
tions, leading to a higher proportion of patients being medically
unsuitable for transplantation. The present study adds new
knowledge about the factors associated with receiving LDKT as
opposed to DDKT among a cohort of patients deemed suitable
to undergo transplantation. This is a select population of
patients who have already successfully navigated the process of
FIGURE 2: Multivariable logistic regression analysis of factors associated with LDKT versus DDKT. N. Ireland, Northern Ireland.
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transplant referral, evaluation and listing. Therefore, it is con-
cerning that the striking disparities observed appear to occur
over and above the well-recognized inequities that patients face
before even reaching this stage. These findings are not confined
to the UK. Our results are consistent with those of a USA study
by Gore et al. [25], which reported lower odds of LDKT relative
to DDKT for patients who were older, from ethnic minority
groups, with lower socio-economic status and with lower levels
of education. Roodnat et al. [26], showed the same factors
reduced the likelihood of LDKT versus DDKT in The
Netherlands. It is interesting that similar results have been dem-
onstrated both within publicly funded as well as private health
care systems, suggesting factors other than financial disadvant-
age play an important role.
The well-recognized markers of socio-economic deprivation
(car ownership and home ownership) were strongly associated
with a reduced likelihood of LDKT versus DDKT in this study.
A subgroup analysis of only White patients confirmed that the
effects of socio-economic deprivation were independent of eth-
nicity. Lower rates of LDKT in socio-economically deprived
patients have also been reported in Australia [27] and the USA
[28, 29]. The reasons behind this finding are unclear. It is
known that living donor–recipient pairs usually come from the
same socio-economic group [30]. In the UK, kidney trans-
plantation including medication and aftercare are provided
free of charge. However, it is possible that other costs such as
transportation, childcare and lost income from time off work
could play a role in deterring potential living donors or
deterring those in need of a kidney from approaching poten-
tial donors [31]. A financial reimbursement policy for
expenses incurred by living donors does exist in the UK, but
it is not implemented consistently by transplant centres. A
recent qualitative study of DDKT recipients found that many
were unaware of the living donor reimbursement policy [32].
Despite this, socio-economically deprived patients did not
perceive financial concerns to be a major barrier to LDKT and
described passivity and disempowerment in treatment decisions,
short-term focus and lack of social support as more significant
obstacles to LDKT [32].
It is well recognized that ethnic minority patients wait
longer for DDKT in the UK, due to the mismatch between
the HLA types of minority patients and those of the predom-
inantly White donor pool [33]. One might, therefore, expect
a higher uptake of LDKT in ethnic minority patients. Our
study found the opposite, with patients from Black and
Asian backgrounds having lower odds of LDKT than DDKT
compared with White patients. Similar disparities have been
reported in the USA [15, 34] and Canada [35]. These dispar-
ities have worsened over time and are likely contributing to
differences in outcomes between White and non-White
patients [36]. The reasons for these disparities are not well
understood. Possible explanations cited include cultural and
religious beliefs [37, 38], reluctance to engage with the medi-
cal system [39, 40], institutional prejudice [41, 42], language
barriers [43] and concern over a higher risk for living donors
from minority ethnic backgrounds [44–46].
We have demonstrated that a patient’s level of educational
attainment is independently associated with their likelihood
of LDKT versus DDKT. Educational attainment is related to
health literacy, which has been shown to be an important
factor for both potential kidney transplant recipients as well
as potential living donors in successfully navigating the living
donation and transplantation process [47, 48]. Higher aca-
demic achievement may be linked to a better ability to under-
stand the benefits of LDKT or to take part in informed and
shared decision making.
The finding that patients who were married or living with a
partner had better access to LDKT is likely to be related to the
opportunity for spousal donation. Spouses represented a consid-
erable proportion (23.3%) of living donors in this study, and the
Table 5. Multivariable logistic regression analysis of factors associated
with LDKT versus DDKT among White patients only
Recipient variables OR (95% CI) P-value
Age group (years)
18–34 1 (reference)
35–49 0.31 (0.22–0.44) <0.0001
50–64 0.17 (0.12–0.25) <0.0001
65–75 0.11 (0.07–0.17) <0.0001
Civil status
Married/living with partner 1 (reference)
Divorced/separated/widowed 0.60 (0.42–0.86) 0.006
Single 0.70 (0.51–0.96) 0.028
Qualifications
Higher education 1 (reference)
Secondary education 0.73 (0.55–0.96) 0.027
No qualifications 0.53 (0.38–0.74) 0.0001
Car ownership
Yes 1 (reference)
No 0.50 (0.35–0.73) 0.0003
Home ownership
Yes 1 (reference)
No 0.68 (0.50–0.91) 0.01
Country
England 1 (reference)
Wales 0.91 (0.56–1.47) 0.693
Northern Ireland 3.43 (1.98–5.95) <0.0001
Scotland 0.71 (0.49–1.04) 0.076
Table 6. Multivariable logistic regression analysis of factors associated
with pre-emptive LDKT
Recipient variables OR (95% CI) P-value
Ethnicity
White 1 (reference)
Asian 0.45 (0.23–0.86) 0.016
Black 1.19 (0.53–2.65) 0.672
Other 1.17 (0.17–7.79) 0.874
Employment status
Employed 1 (reference)
Unemployed 0.44 (0.21–0.92) 0.029
Long-term sick/disability 0.44 (0.28–0.68) 0.0002
Retired 0.47 (0.29–0.75) 0.002
Other 1.41 (0.80–2.50) 0.240
Car ownership
Yes 1 (reference)
No 0.41 (0.19–0.86) 0.018
Home ownership
Yes 1 (reference)
No 0.65 (0.44–0.96) 0.029
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|majority were female (61.7%). Beingmarried or living with a part-
ner may also confer other benefits, such as having a better social
support network or access to more unrelated or child donors.
Older age was associated with dramatically reduced odds of
LDKT versus DDKT. Previous research has demonstrated that
older age is associated with a lower probability of attempted
donor recruitment [49]. Older patients have reported an unwill-
ingness to put younger donors at risk, particularly their children
[50]. In our study, 18.2% of the living donors were parents while
only 9.3% were children.
Despite adjustment for demographic and socio-economic
factors, we found striking geographic differences in LDKT activ-
ity, with patients in NI experiencing higher odds of LDKT versus
DDKT compared with patients in England, Wales and Scotland.
Our results reflect the actual number of LDKTs pmp, which
were around twice as high in NI (31.1) compared with the rest of
the UK (England 15.9, Wales 16.6, Scotland 10.9) at the time of
the study [51]. Around this time, an initiative was begun in NI
to promote LDKT and pre-emptive transplant as the treatment
of choice. The key measures included education to promote a
change of mindset among nephrologists (particularly non-
transplant nephrologists) as well as the entire transplant
team, together with improved infrastructure and more
streamlined services to enable timely workup and transplan-
tation (e.g. one-stop living donor assessment clinic).
Effective leadership, persistence and gaining the support of
commissioners and management were critical in achieving
these changes [A. Courtney (personal communication, 17
January 2017)]. Our results and the national figures indicate
that such a strategy can be very successful in increasing
LDKT utilization. The higher LDKT rate in NI led to a lower
DDKT rate (NI 15.0, England 24.9, Wales 33.0, Scotland
26.7) [51] and there are now very few long-waiting patients
on the waiting list in NI [52]. Moreover, the number of
LDKTs in NI has continued to increase (40 pmp in 2016,
one of the highest rates in the world), demonstrating that the
changes have led to a sustained improvement rather than
a temporary peak in activity. This is encouraging when
exploring potential avenues to improve LDKT across the UK
as a whole.
Our study showed for the first time in the UK that socio-
economic deprivation, unemployment and Asian ethnicity were
independently associated with a lower likelihood of pre-emptive
LDKT. These findings are consistent with studies from the USA
and Australia [5, 25, 27]. The disparity experienced by socio-
economically deprived individuals is likely to be related to an
increased likelihood of late referral to specialist renal services in
the UK [53]; however, this does not explain the disparity for
patients of Asian ethnicity.
LDKT, and in particular pre-emptive LDKT, provides opti-
mal clinical outcomes for patients with ESRD, yet its uptake is
variable within the UK. This study has identified specific patient
groups with a lower likelihood of undergoing LDKT relative to
DDKT. We have demonstrated that demographic, socio-
economic and geographic factors are more strongly associated
with the type of transplant received rather than clinical factors,
including comorbidity, primary renal diagnosis, HLA sensitiza-
tion or previous transplantation. Moreover, a remarkable
finding is that even among LDKT recipients, disparities persist
in receiving pre-emptive transplantation. This demonstrates the
strength of social factors in influencing access to health care and
may reflect similar inequities across a wide range of health care
services. The demonstrated disparities may reflect both barriers
in certain patient groups as well as important positive factors in
others. Furthermore, these influencing factors are likely to apply
to both potential recipients and donors. If particular groups
experience avoidable barriers to LDKT receiving or donating,
there is a responsibility to provide tailored resources to remove
these barriers. Improving access to LDKT will not only benefit
individual patients, but will also have favourable effects for the
wider ESRD population by effectively increasing the overall
pool of available organs. However, both donor and recipient
welfare and autonomy undoubtedly remain the primary focus.
Some patients may prefer not to pursue LDKT due to concerns
about risks to their potential donors, just as some potential
donors may be unwilling to donate [50, 54].
Identifying disadvantaged patient groups is essential to
directing further research into potentially modifiable factors
and appropriate interventions. Several studies in the USA have
explored targeted interventions, including culturally sensitive
education programmes [55, 56], home-based education [57, 58]
and patient advocates [59], with promising results for reducing
disparities in LDKT. Similar programmes in the UK may pro-
vide a more equitable opportunity for disadvantaged patients to
explore the option of LDKT.
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